Hosted in San Diego, the DIA Global Annual Meeting celebrated 60 years of innovation and provided an excellent forum for networking and discussing challenges in the industry. Alphalife Sciences proudly hosted a booth, showcasing our cutting-edge clinical research solutions powered by generative AI, which garnered significant interest and inquiries.

In an interview with Fox News, CEO Sharon Chen and Larry Veal, Head of Marketing and Business Development for North America and Europe, highlighted our mission to revolutionize clinical trials. We are developing a unified, intelligent platform that enhances trial speed and efficiency while maintaining high quality. Our team, with experience from tech giants like Google and Microsoft and extensive clinical trial expertise, combines technology and knowledge to eliminate human errors through automation. By ensuring data is clean and structured, and utilizing advanced AI for unstructured data, we streamline processes and improve interdisciplinary communication. Our flexible approach meets the unique needs of large pharma companies, helping them deliver crucial medicines to patients more quickly.

Visit our company website: www.alphalifesci.com

свернуть